Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies
Company
About us Our technology Operations Management Board of directors
Contact
Management Sales Investor relations
Type and search

All notices

ENTERS INTO A CONSULTANCY AGREEMENT WITH JAMES BERGER – CONTEMPLATED US LISTING

18.10.2019

CORRECTION: Second Quarter 2019 Financial Report

02.10.2019

SHARE CAPITAL INCREASE REGISTERED

01.10.2019

Important protein hydrolysis patent granted by the European Patent Office

30.09.2019

ESTABLISHES MANAGEMENT INCENTIVE PROGRAM – LARGE SHAREHOLDER DISCLOSURE

23.09.2019

LAST DAY OF SUBSCRIPTION PERIOD

16.09.2019

FURTHER INFORMATION ABOUT THE SUBSEQUENT OFFERING – SUBSCRIPTION PERIOD COMMENCING TODAY

02.09.2019

Second Quarter 2019 Financial Report

30.08.2019

Completed Extraordinary General meeting and approved repair issue

30.08.2019

SHARE CAPITAL INCREASE REGISTERED

19.08.2019

Previous
4 5 6
7
8 9 10
...
27
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies
Company
About us Our technology Operations Management Board of directors
Contact
Management Sales Investor relations

Copyright 2021 Hofseth BioCare ASA
Privacy cookies